Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

416 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases trial results

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

NCT03263273

Conditions
Papulopustular Rosacea, Rosacea, Skin Diseases, +2 more
Locations
  • Clinical Site - 15 Bryant, Arkansas, United States
  • Clinical Site - 20 Rogers, Arkansas, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
  • Clinical Site - 19 Santa Monica, California, United States
View all 23 locations
View Trial Details
Completed

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

NCT01490632

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bakersfield, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santa Monica, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miramar, Florida, United States
View all 35 locations
View Trial Details
Completed

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)

NCT03269773

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Pusan National University Hospital Busan, South Korea
  • Chonnam National University Hospital Gwangju, South Korea
  • Dongguk University Medical Center Ilsan, South Korea
  • Gachon University Gil Medical Center Incheon, South Korea
View Trial Details
Completed

Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis

NCT03054428

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +16 more
Locations
  • Regeneron Investigational Site Birmingham, Alabama, United States
  • Regeneron Investigational Site Gilbert, Arizona, United States
  • Regeneron Investigational Site Bakersfield, California, United States
  • Regeneron Investigational Site Long Beach, California, United States
View all 45 locations
View Trial Details
Completed

An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis

NCT01743560

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Novartis Investigative Site Epping, Essex, United Kingdom
  • Novartis Investigative Site Inverness, Invernesshire, United Kingdom
  • Novartis Investigative Site Ipswich, Suffolk, United Kingdom
  • Novartis Investigative Site Sutton, Surrey, United Kingdom
View Trial Details

Related conditions